Data gathered: May 30
Alternative Data for Sophia Genetics SA
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 38,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 219 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Sophia Genetics SA
None
| Price | $2.90 |
| Target Price | Sign up |
| Volume | 28,200 |
| Market Cap | $192M |
| Year Range | $2.66 - $4.88 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Biotechnology |
In the news
 |
SOPHiA GENETICS SA 2025 Q1 - Results - Earnings Call PresentationMay 9 - SeekingAlpha |
|
SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call TranscriptMay 9 - SeekingAlpha |
SOPHiA GENETICS Reports First Quarter 2025 ResultsMay 5 - Finnhub |
|
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025April 21 - Finnhub |
|
Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy CapabilitiesApril 8 - Finnhub |
|
 |
Mesoblast (NASDAQ:MESO) versus SOPHiA GENETICS (NASDAQ:SOPH) Critical AnalysisApril 2 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 18M | 5.6M | 12M | -17M | -14M | -0.260 |
| Q4 '24 | 18M | 5.6M | 12M | -15M | -12M | -0.120 |
| Q3 '24 | 16M | 5.2M | 11M | -18M | -13M | -0.278 |
| Q2 '24 | 16M | 5M | 11M | -15M | -13M | -0.230 |
| Q1 '24 | 16M | 5.4M | 10M | -14M | -17M | -0.210 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Sophia Genetics SA (SOPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Sophia Genetics SA?
The Market Cap of Sophia Genetics SA is $192M.
What is the current stock price of Sophia Genetics SA?
Currently, the price of one share of Sophia Genetics SA stock is $2.90.
How can I analyze the SOPH stock price chart for investment decisions?
The SOPH stock price chart above provides a comprehensive visual representation of Sophia Genetics SA's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sophia Genetics SA shares. Our platform offers an up-to-date SOPH stock price chart, along with technical data analysis and alternative data insights.
Does SOPH offer dividends to its shareholders?
As of our latest update, Sophia Genetics SA (SOPH) does not offer dividends to its shareholders. Investors interested in Sophia Genetics SA should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Sophia Genetics SA?
Some of the similar stocks of Sophia Genetics SA are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.